Keyword Index

Browse for an article via relevant keywords across our entire electronic archive

Search results for: P
Results 1 - 10 of 834 shown below

  • P urinaria

    P Giridharan, S T Somasundaram, K Perumal, R A Vishwakarma, N P Karthikeyan, R Velmurugan and A Balakrishnan

    Novel substituted methylenedioxy lignan suppresses proliferation of cancer cells by inhibiting telomerase and activation of c-myc and caspases leading to apoptosis

    doi:10.1038/sj.bjc.6600422

    Abstract | Full article | PDF

  • p-boronophenylalanine

    G M Morris, D R Smith, H Patel, S Chandra, G H Morrison, J W Hopewell, M Rezvani, P L Micca and J A Coderre

    Boron microlocalization in oral mucosal tissue: implications for boron neutron capture therapy

    doi:10.1054/bjoc.2000.1148

    Abstract | Full article | PDF

  • p-dimethylaminoazobenzene

    F Caballero, E Gerez, A Batlle and E Vazquez

    Interaction of cimetidine with P450 in a mouse model of hepatocarcinogenesis initiation

    doi:10.1038/sj.bjc.6600102

    Abstract | Full article | PDF

  • P-Glycoprotein

    J-H Choi, H-Y Lim, H J Joo, H S Kim, J W Yi, H C Kim, Y K Cho, M W Kim and K B Lee

    Expression of multidrug resistance-associated protein1,P-glycoprotein, and thymidylate synthase in gastric cancer patients treated with 5-fluorouracil and doxorubicin-based adjuvant chemotherapy after curative resection

    doi:10.1038/sj.bjc.6600305

    Abstract | Full article | PDF

  • A J Zurita, J E Diestra, E Condom, X García del Muro, G L Scheffer, R J Scheper, J Pérez, J R Germà-Lluch and M A Izquierdo

    Lung resistance-related protein as a predictor of clinical outcome in advanced testicular germ-cell tumours

    doi:10.1038/sj.bjc.6600803

    Abstract | Full article | PDF

  • C Martin, J Walker, A Rothnie and R Callaghan

    The expression of P-glycoprotein does influence the distribution of novel fluorescent compounds in solid tumour models

    doi:10.1038/sj.bjc.6601300

    Abstract | Full article | PDF

  • E Yagüe and S Raguz

    Drug resistance in cancer

    advance online publication, 2005-10-18 00:00:00.000;

    doi:10.1038/sj.bjc.6602821

    Abstract | Full article | PDF

  • X F Hu, J Li, E Yang, S Vandervalk and P X Xing

    Anti-Cripto Mab inhibit tumour growth and overcome MDR in a human leukaemia MDR cell line by inhibition of Akt and activation of JNK/SAPK and bad death pathways

    advance online publication, 2007-03-06 00:00:00.000;

    doi:10.1038/sj.bjc.6603641

    Abstract | Full article | PDF

  • J Bart, W B Nagengast, R P Coppes, T D Wegman, W T A van der Graaf, H J M Groen, W Vaalburg, E G E de Vries and N H Hendrikse

    Irradiation of rat brain reduces P-glycoprotein expression and function

    advance online publication, 2007-07-03 00:00:00.000;

    doi:10.1038/sj.bjc.6603864

    Abstract | Full article | PDF

  • Y Mi and L Lou

    ZD6474 reverses multidrug resistance by directly inhibiting the function of P-glycoprotein

    advance online publication, 2007-10-02 00:00:00.000;

    doi:10.1038/sj.bjc.6603985

    Abstract | Full article | PDF

  • J van Asperen, O van Tellingen, F Tijssen, A H Schinkel and J H Beijnen

    Increased accumulation of doxorubicin and doxorubicinol in cardiac tissue of mice lacking mdr1a P-glycoprotein

    doi:10.1038/sj.bjc.6690019

    Abstract | Full article | PDF

  • A Wallstab, M Koester, M Böhme and D Keppler

    Selective inhibition of MDR1 P-glycoprotein-mediated transport by the acridone carboxamide derivative GG918

    doi:10.1038/sj.bjc.6690169

    Abstract | Full article | PDF

  • M-G Côme, A Skladanowski and G Laurent

    Dual mechanism of daunorubicin-induced cell death in both sensitive and MDR-resistant HL-60 cells

    doi:10.1038/sj.bjc.6690174

    Abstract | Full article | PDF

  • P Mistry, J Plumb, S Eccles, S Watson, I Dale, H Ryder, G Box, P Charlton, D Templeton and P B Bevan

    In vivo efficacy of XR9051, a potent modulator of P-glycoprotein mediated multidrug resistance

    doi:10.1038/sj.bjc.6690267

    Abstract | Full article | PDF

  • J C Taylor, D R Ferry, C F Higgins and R Callaghan

    The equilibrium and kinetic drug binding properties of the mouse P-gp1a and P-gp1b P-glycoproteins are similar

    doi:10.1038/sj.bjc.6690764

    Abstract | Full article | PDF

  • H Takeshita, K Kusuzaki, H Murata, T Suginoshita, M Hirata, S Hashiguchi, T Ashihara, M C Gebhardt, H J Mankin and Y Hirasawa

    Osteoblastic differentiation and P-glycoprotein multidrug resistance in a murine osteosarcoma model

    doi:10.1054/bjoc.1999.1099

    Abstract | Full article | PDF

  • G K Chen, G E Durán, A Mangili, L Beketic-Oreskovic and B I Sikic

    MDR 1 activation is the predominant resistance mechanism selected by vinblastine in MES-SA cells

    doi:10.1054/bjoc.2000.1371

    Abstract | Full article | PDF

  • C Ferlini, M Distefano, F Pignatelli, S Lin, A Riva, E Bombardelli, S Mancuso, I Ojima and G Scambia

    Antitumour activity of novel taxanes that act at the same time as cytotoxic agents and P-glycoprotein inhibitors

    doi:10.1054/bjoc.2000.1500

    Abstract | Full article | PDF

  • M M Malingré, J H Beijnen, H Rosing, F J Koopman, R C Jewell, E M Paul, W W Ten Bokkel Huinink and J H M Schellens

    Co-administration of GF120918 significantly increases the systemic exposure to oral paclitaxel in cancer patients

    doi:10.1054/bjoc.2000.1543

    Abstract | Full article | PDF

  • T Muzzammil, M J Moore, D Hedley and J R Ballinger

    Comparison of 99mTc-sestamibi and doxorubicin to monitor inhibition of P-glycoprotein function

    doi:10.1054/bjoc.2000.1621

    Abstract | Full article | PDF

  • J M Sargent, C J Williamson, C Yardley, C G Taylor and K Hellmann

    Dexrazoxane significantly impairs the induction of doxorubicin resistance in the human leukaemia line, K562

    doi:10.1054/bjoc.2001.1697

    Abstract | Full article | PDF

  • H A Cocker, S M Hobbs, N Tiffin, K Pritchard-Jones, C R Pinkerton and L R Kelland

    High levels of the MDM2 oncogene in paediatric rhabdomyosarcoma cell lines may confer multidrug resistance

    doi:10.1054/bjoc.2001.2145

    Abstract | Full article | PDF

  • M Bebawy, M B Morris and B D Roufogalis

    Selective modulation of P-glycoprotein-mediated drug resistance

    doi:10.1054/bjoc.2001.2184

    Abstract | Full article | PDF

  • P-glycoprotein inhibitor

    H C L Traunecker, M C G Stevens, D J Kerr and D R Ferry

    The acridonecarboxamide GF120918 potently reverses P-glycoprotein-mediated resistance in human sarcoma MES-Dx5 cells

    doi:10.1038/sj.bjc.6690791

    Abstract | Full article | PDF

  • P-gp expression

    E Erba, D Bergamaschi, L Bassano, S Ronzoni, G Di Liberti, I Muradore, S Vignati, G Faircloth, J Jimeno and M D'Incalci

    Isolation and characterization of an IGROV-1 human ovarian cancer cell line made resistant to Ecteinascidin-743 (ET-743)

    doi:10.1054/bjoc.2000.1224

    Abstract | Full article | PDF

  • P-selectin

    L Ding, M Sunamura, T Kodama, J Yamauchi, D G Duda, H Shimamura, K Shibuya, K Takeda and S Matsuno

    In vivo evaluation of the early events associated with liver metastasis of circulating cancer cells

    doi:10.1054/bjoc.2001.1911

    Abstract | Full article | PDF

  • P-subunit

    N Konishi, K Tsujikawa, H Yamamoto, E Ishida, M Nakamura, K Shimada, K Yane, H Yamashita and S Noguchi

    Overexpression of leucocyte common antigen (LAR) P-subunit in thyroid carcinomas

    doi:10.1038/sj.bjc.6600876

    Abstract | Full article | PDF

  • P13'

    K M Woods Ignatoski, T Maehama, S M Markwart, J E Dixon, D L Livant and S P Ethier

    ERBB-2 overexpression confers PI 3 ' kinase-dependent invasion capacity on human mammary epithelial cells

    doi:10.1054/bjoc.1999.0979

    Abstract | Full article | PDF

  • P13K

    J Snaddon, E K Parkinson, J A Craft, C Bartholomew and R Fulton

    Detection of functional PTEN lipid phosphatase protein and enzyme activity in squamous cell carcinomas of the head and neck, despite loss of heterozygosity at this locus

    doi:10.1054/bjoc.2001.1848

    Abstract | Full article | PDF